Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Platelet Inhibition With CANgrelor and Crushed TICagrelor in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: The CANTIC Study

NCT03247738 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT03247738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03247738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Platelet Inhibition With CANgrelor and Crushed TICagrelor in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: The CANTIC Study
Lead sponsor
University of Florida
Phase
Phase 4
Overall status
Completed
Start date
November 20, 2017
Completion date
December 13, 2018
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

percutaneous coronary intervention, st segment elevation myocardial infarction